VBI Vaccines Inc.
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PREHEVBRIO Pregnancy Outcomes Registry (NCT06097312) | VBI Vaccines Inc. | 2023-11-30 |
| Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant (NCT05614245) | VBI Vaccines Inc. | 2023-03-01 |
| Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a (NCT05548439) | VBI Vaccines Inc. | 2022-10-05 |
| Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a (NCT04773665) | VBI Vaccines Inc. | 2021-03-15 |
| Lot-to-lot Consistency of Sci-B-Vac™ in Adults (NCT03408730) | VBI Vaccines Inc. | 2017-12-14 |
| Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults (NCT03393754) | VBI Vaccines Inc. | 2017-12-13 |
| Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects (NCT03382977) | VBI Vaccines Inc. | 2017-12-06 |
Track VBI Vaccines Inc. automatically
Every clearance here is in the API, with alerts when new ones post.